Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
11:12:12 EDT Tue 22 Sep 2026
Enter Symbol
or Name
USA
CA



Q:ELTP - ELITE PHARMACEUTICALS INC - https://www.elitepharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ELTP - Qnot subscribed0.24446+0.002260.9160.738370.2421  0.248  0.240.6943  0.24110:36:17Aug 1315 min RT 2¢

Recent Trades - Last 10 of 37
Time ETExPriceChangeVolume
10:36:17Q0.244460.00226500
10:35:45Q0.244460.00226500
10:35:17Q0.2480.005830,000
10:32:31Q0.2480.0058100
10:28:59Q0.244460.00226365
10:27:46Q0.245640.0034415
10:23:41Q0.245050.00285100
10:13:13Q0.2450.002815,000
10:04:04Q0.24650.0043100
09:57:19Q0.24410.0019500

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-08-13 16:12U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2027 Ended June 30, 2026 and Provides Conference Call Information
2026-08-10 16:55U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter of Fiscal Year 2027 Financial Results on August 14, 2026
2026-08-04 07:01U:ELTPNews ReleaseElite Pharmaceuticals Announces Commercial Launch of Generic Requip XL
2026-06-29 16:30U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2026 and Provides Conference Call Information
2026-06-23 07:01U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2026 Financial Results on June 30, 2026
2026-06-15 07:01U:ELTPNews ReleaseElite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
2026-06-01 07:02U:ELTPNews ReleaseElite Pharmaceuticals Announces Filing of Abbreviated New Drug Application with the U.S. Food and Drug Administration for Generic Anticoagulant Product
2026-04-02 08:01U:ELTPNews ReleaseElite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets
2026-02-17 16:20U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information
2026-02-11 16:31U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026
2025-11-14 16:20U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information
2025-11-12 07:02U:ELTPNews ReleaseElite Pharmaceuticals Receives FDA Approval for Generic Requip XL(R)
2025-11-10 07:01U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025